Metoprolol Krka

Metoprolol Succinate, the active ingredient in Metoprolol Krka, is a beta blocker presented as a tablet for oral use. It treats hypertension, angina pectoris, heart failure and post‑myocardial infarction in adult patients.

GNH USA supplies Metoprolol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Krka is a selective β1‑adrenergic blocker used in cardiovascular disease management. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Heart failure: improves left‑ventricular function and reduces hospitalisation. - Post‑myocardial infarction: lowers the chance of recurrent ischemic events and improves survival.

Metoprolol Krka may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea or abdominal discomfort. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Severe bradycardia: heart rate dropping to dangerously low levels. - Heart block: impaired electrical conduction in the heart. - Hypotension: significant drop in blood pressure causing faintness. - Bronchospasm: narrowing of airways, particularly in asthmatic patients. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Depression or mood changes: emerging or worsening depressive symptoms.

Before initiating Metoprolol Krka, clinicians should consider several safety measures. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess cardiac function: evaluate heart rate and rhythm, especially in patients with conduction disorders. - Adjust in renal/hepatic impairment: dose may need modification in reduced organ function. - Caution in asthma/COPD: β1‑selectivity may still affect bronchial tone. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol Krka can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Verapamil or diltiazem: combined effect may cause severe bradycardia or heart block. - Clonidine withdrawal: abrupt stop of clonidine while on metoprolol can precipitate hypertension. - Amiodarone: may increase metoprolol plasma levels, leading to excessive β‑blockade.

Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycemics: metoprolol can mask hypoglycaemia symptoms. - NSAIDs: may reduce antihypertensive effect of metoprolol, requiring BP monitoring.